XHKG
3309
Market cap117mUSD
Oct 09, Last price
0.76HKD
1D
-2.58%
1Q
-17.93%
IPO
-89.73%
Name
C-Mer Eye Care Holdings Ltd
Chart & performance
P/E
8.95
P/S
0.46
EPS
0.08
Div yield, %
2.58%
Shrs. gr., 5y
1.77%
Rev. gr., 5y
22.71%
Revenues
1.95b
+1.75%
Net income
100m
P
CFO
301m
+6.48%
Dividend
Jun 29, 20260.03 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
C-MER Medical Holdings Limited specializes in offering both medical treatments and therapeutic services for a variety of eye conditions. Its business activities are segmented into two primary areas: the delivery of ophthalmological services and the retail of vision-enhancing products. Established by Shun Chiu Lam on February 1, 2016, the organization's corporate headquarters are situated in Hong Kong.
Key people
Shun Chiu Lam
Executive Chairman of the Board, Chief Executive Officer
Yau Wing Lee
Executive Director, Head of Hong Kong Operation
Xiaoting Li
Executive Director · since 2017
Man Yi Siu
Chief Operation Officer, Hong Kong · since 2022
Wa Ping Chan
Chief Financial Officer, Company Secretary · since 2017
Non-Executive Independent Vice Chairman of the Board · since 2021
Shu Kwan Ip
Non-Executive Independent Director · since 2020
Ling Cheung Li
Independent Non-Executive Director · since 2025
Chiu Cheung Ma
Non-Executive Independent Director · since 2017
Non-Executive Independent Director · since 2023
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||